SPTX and PRTC Related Headlines

Go Back

Jun 9, 2026 02:00AM Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
Jun 9, 2026 02:00AM PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers

SPTX and PRTC Related Press Releases

Go Back

Jun 9, 2026 02:00AM PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers

SPTX and PRTC Related SEC Filings

Go Back